학술논문
Orismilast in moderate-to-severe psoriasis: Efficacy and safety from a 16-week, randomized, double-blinded, placebo-controlled, dose-finding, and phase 2b trial (IASOS)
Document Type
Article
Author
Source
In: Journal of the American Academy of Dermatology . (Journal of the American Academy of Dermatology, March 2024, 90(3):494-503)
Subject
Language
English
ISSN
10976787
01909622
01909622